Ceftriaxone Dosing for 17-Year-Old Male, 52 kg
For a 17-year-old male weighing 52 kg, administer ceftriaxone 2 g IV every 12 hours for most serious bacterial infections, as this patient should be dosed as an adult given his age.
Rationale
At 17 years old, this patient falls into the adult dosing category despite his lower body weight. The UK Joint Specialist Societies guidelines clearly delineate that patients aged >18 years receive 2 g every 12 hours for serious infections like meningitis, sepsis, and pneumonia 1. While this patient is technically 17, he is at the threshold of adult dosing and his weight (52 kg) is within the range where adult fixed dosing is appropriate.
Specific Dosing by Indication
For Meningitis or Suspected CNS Infection
- Dose: 2 g IV every 12 hours (or 4 g once daily) 1, 2
- This provides adequate CNS penetration with concentrations well above MIC for common pathogens
- Duration: 5-14 days depending on pathogen (5 days for meningococcal, 10-14 days for pneumococcal) 1
For Sepsis/Bacteremia Without CNS Involvement
- Dose: 2 g IV every 12 hours 1
- Alternative: 2 g IV every 24 hours may be considered for less severe infections 3
For Pneumonia
- Dose: 2 g IV every 12 hours initially, can transition to once daily if clinically stable 4
- Recent evidence suggests 2 g daily may be adequate for non-severe pneumonia, but 2 g every 12 hours is preferred for severe cases 4
For Urinary Tract Infection
- Dose: 2 g IV every 24 hours is adequate 5
- Can transition to oral therapy once clinically stable
Important Caveats
Weight-based dosing consideration: While adult fixed dosing is appropriate here, if you prefer weight-based dosing for this borderline patient:
- 50-80 mg/kg/day would yield 2,600-4,160 mg/day for his 52 kg weight
- This translates to approximately 1.3-2 g every 12 hours, supporting the 2 g every 12 hours recommendation 3, 6
Renal function: No dose adjustment needed unless severe renal impairment is present (the patient should not exceed 2 g daily if both severe renal AND hepatic dysfunction exist) 7
Maximum daily dose: Do not exceed 4 g/day in adults 7
Monitoring: Watch for gallbladder pseudolithiasis and urolithiasis, particularly given his younger age where this complication is more common 7
Practical Administration
- Administer as 30-minute IV infusion 7
- Can be given IM if IV access is problematic (though less ideal for serious infections)
- Peak concentrations after 2 g IV dose reach approximately 257 mg/L 7
- Trough concentrations remain therapeutic for most pathogens with MIC ≤1 mg/L 8
The key decision point is treating this 17-year-old as an adult rather than a pediatric patient, which is appropriate given his age and supports the 2 g every 12 hours dosing for serious infections.